USD 0.36
(-2.07%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 41.26 Million USD | 58.35% |
2022 | 26.05 Million USD | 9.45% |
2021 | 23.8 Million USD | -11.66% |
2020 | 26.95 Million USD | -69.15% |
2019 | 87.36 Million USD | -3.14% |
2018 | 90.19 Million USD | -45.14% |
2017 | 164.4 Million USD | 8.75% |
2016 | 151.17 Million USD | 12.66% |
2015 | 134.18 Million USD | 275.59% |
2014 | 35.72 Million USD | 9.19% |
2013 | 32.71 Million USD | 8.12% |
2012 | 30.26 Million USD | 71.28% |
2011 | 17.66 Million USD | 7.85% |
2010 | 16.38 Million USD | 182.41% |
2009 | 5.8 Million USD | 4418.45% |
2008 | 128.38 Thousand USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 46.25 Million USD | 12.09% |
2024 Q2 | 50.57 Million USD | 9.34% |
2023 FY | 41.26 Million USD | 58.35% |
2023 Q3 | 37.32 Million USD | 8.94% |
2023 Q4 | 41.26 Million USD | 10.56% |
2023 Q1 | 30.6 Million USD | 17.45% |
2023 Q2 | 34.25 Million USD | 11.94% |
2022 FY | 26.05 Million USD | 9.45% |
2022 Q1 | 23.88 Million USD | 0.33% |
2022 Q2 | 24.56 Million USD | 2.86% |
2022 Q4 | 26.05 Million USD | 11.95% |
2022 Q3 | 23.27 Million USD | -5.26% |
2021 FY | 23.8 Million USD | -11.66% |
2021 Q2 | 25.79 Million USD | 1.82% |
2021 Q3 | 23.15 Million USD | -10.23% |
2021 Q4 | 23.8 Million USD | 2.83% |
2021 Q1 | 25.33 Million USD | -6.01% |
2020 Q1 | 89.02 Million USD | 1.91% |
2020 Q2 | 88.52 Million USD | -0.56% |
2020 Q3 | 90.37 Million USD | 2.09% |
2020 Q4 | 26.95 Million USD | -70.18% |
2020 FY | 26.95 Million USD | -69.15% |
2019 Q1 | 86.24 Million USD | -4.38% |
2019 FY | 87.36 Million USD | -3.14% |
2019 Q2 | 85.57 Million USD | -0.77% |
2019 Q4 | 87.36 Million USD | 1.7% |
2019 Q3 | 85.89 Million USD | 0.38% |
2018 Q4 | 90.19 Million USD | 4.13% |
2018 Q2 | 92.49 Million USD | 3.73% |
2018 Q1 | 89.17 Million USD | -45.76% |
2018 FY | 90.19 Million USD | -45.14% |
2018 Q3 | 86.61 Million USD | -6.36% |
2017 Q1 | 151.36 Million USD | 0.12% |
2017 FY | 164.4 Million USD | 8.75% |
2017 Q4 | 164.4 Million USD | 3.6% |
2017 Q3 | 158.68 Million USD | 1.99% |
2017 Q2 | 155.58 Million USD | 2.79% |
2016 Q4 | 151.17 Million USD | 2.46% |
2016 FY | 151.17 Million USD | 12.66% |
2016 Q2 | 141.8 Million USD | 2.73% |
2016 Q1 | 138.02 Million USD | 2.87% |
2016 Q3 | 147.54 Million USD | 4.05% |
2015 Q3 | 129.05 Million USD | 237.84% |
2015 Q2 | 38.2 Million USD | 0.86% |
2015 Q4 | 134.18 Million USD | 3.97% |
2015 Q1 | 37.87 Million USD | 6.02% |
2015 FY | 134.18 Million USD | 275.59% |
2014 Q2 | 36.37 Million USD | -3.77% |
2014 Q1 | 37.79 Million USD | 15.52% |
2014 Q4 | 35.72 Million USD | -1.5% |
2014 FY | 35.72 Million USD | 9.19% |
2014 Q3 | 36.27 Million USD | -0.29% |
2013 Q4 | 32.71 Million USD | 3.3% |
2013 Q1 | 30.08 Million USD | -0.58% |
2013 Q2 | 31.68 Million USD | 5.3% |
2013 Q3 | 31.67 Million USD | -0.03% |
2013 FY | 32.71 Million USD | 8.12% |
2012 FY | 30.26 Million USD | 71.28% |
2012 Q1 | 17.72 Million USD | 0.32% |
2012 Q2 | 18.3 Million USD | 3.3% |
2012 Q3 | 29.85 Million USD | 63.06% |
2012 Q4 | 30.26 Million USD | 1.37% |
2011 Q4 | 17.66 Million USD | 20.01% |
2011 FY | 17.66 Million USD | 7.85% |
2011 Q3 | 14.72 Million USD | 36.48% |
2011 Q2 | 10.78 Million USD | -3.88% |
2011 Q1 | 11.22 Million USD | -31.49% |
2010 Q2 | 7.09 Million USD | 47613.57% |
2010 FY | 16.38 Million USD | 182.41% |
2010 Q4 | 16.38 Million USD | 21.47% |
2010 Q3 | 13.48 Million USD | 90.13% |
2010 Q1 | 14.86 Thousand USD | -63.65% |
2009 Q4 | 40.89 Thousand USD | 154.03% |
2009 FY | 5.8 Million USD | 4418.45% |
2009 Q3 | 16.09 Thousand USD | 0.0% |
2008 Q4 | 128.38 Thousand USD | 0.0% |
2008 FY | 128.38 Thousand USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Electromed, Inc. | 8.34 Million USD | -394.76% |
Myomo, Inc. | 5.59 Million USD | -637.865% |
Senseonics Holdings, Inc. | 64.76 Million USD | 36.291% |
Catheter Precision, Inc. | 9.54 Million USD | -332.345% |